Overview Fundamentals API Earnings EOD API Sample Code Pricing

Pyxis Oncology Inc (PYXS NASDAQ) stock market data APIs

$3.95 0.07(1.8%) as of July 26, 2024
Price chart is built with Anychart

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 clinical trial to treat patients with advanced solid tumors. The company is also developing PYX-107, a CD40 agonist with demonstrated anti-cancer activity in patients who previously progressed on PD-(L)1 inhibitors, which is in Phase 2 clinical trial for the treatment of solid tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction, cancers, and melanoma in combination with chemotherapy, radiation therapy, and immunotherapy. It has in-license agreement with Pfizer Inc. to develop and commercialize ADC product candidates directed to certain licensed targets, including PYX-201 and PYX-203, and products containing the ADC product candidates; and Biosion USA, Inc. for development, manufacture, and commercialization of PYX-106, an IO product candidate. Pyxis Oncology, Inc. was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Pyxis Oncology Inc Financial Data Overview

3.88
3.95
-
4.05
3.81
1.35-6.85
227 M
58 889 K
16 146 K
-0.06
1.283
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PYXS',
Type: 'Common Stock',
Name: 'Pyxis Oncology Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00PQFFCV5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1782223',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-10-08',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Pyxis Oncology Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 16 146 K
  • EBITDA -61 457 000
  • Earnings Per Share -1.37
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Pyxis Oncology Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.24

Get Pyxis Oncology Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com